Anti-Nuclear Antibodies (Direct)
Anti-Nuclear Antibodies (Direct) is a clinical biomarker on the Autoimmune panel, reported in titer. Standard reference range: 0–120 titer. Functional (optimal) range used by integrative practitioners: 0–0 titer.
What is Anti-Nuclear Antibodies (Direct)?
Direct ANA testing (as opposed to indirect immunofluorescence) detects autoantibodies to nuclear antigens; results should be interpreted alongside specific autoantibody panels and clinical findings.
Reference ranges
| Range type | Value (titer) | Source |
|---|---|---|
| Standard (lab) | 0–120 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 0–0 | Integrative / functional medicine consensus |
How SomaVue interprets Anti-Nuclear Antibodies (Direct)
SomaVue maps every result for Anti-Nuclear Antibodies (Direct) against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for Anti-Nuclear Antibodies (Direct) and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.